CISI FIN (06058) announced that the appointments of Mr. Lin Dan as an Executive Director of the Company and Ms. Ye Jianfang as an Independent Non-Executive Director of the Company were approved at the Extraordinary General Meeting, effective from January 23, 2026.

The Board further announced that, to devote more time to other personal commitments, Ms. Zhang has resigned as the Chief Executive Officer of the Company, effective from January 23, 2026.

Following Ms. Zhang's departure as CEO, Executive Director Mr. Lin was appointed as the Chief Executive Officer, effective from January 23, 2026.

The Board further announced that, to devote more time to other personal commitments, Mr. Chen Haorong has resigned as an Independent Non-Executive Director of the Company, effective from January 23, 2026.

The Board further announced that, effective from January 23, 2026, Mr. Chen has ceased to be the Chairman of the Audit Committee under the Board.

Ms. Ye has succeeded Mr. Chen as the Chairman of the Audit Committee under the Board.

The Board further announced that Ms. Zhang has ceased to be an Authorized Representative of the Company under Rule 3.05 of the Listing Rules, effective from January 23, 2026.

Mr. Lin, an Executive Director of the Company, has been appointed as the Authorized Representative, effective from January 23, 2026.

The Board further announced that Ms. Zhang has ceased to be the authorized representative of the Company in Hong Kong for receiving legal process documents and notices under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective from January 23, 2026.

Mr. Lin, an Executive Director of the Company, has been appointed as the agent for service of legal process to succeed Ms. Zhang, effective from January 23, 2026.